Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-076897
Filing Date
2026-02-26
Accepted
2026-02-26 16:30:04
Documents
1
Period of Report
2026-02-24

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5693
  Complete submission text file 0001193125-26-076897.txt   7144
Mailing Address 100 SUMMER ST SUITE 2300 BOSTON MA 02109
Business Address
Emany Sravan Kumar (Reporting) CIK: 0001897662 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41947 | Film No.: 26689323

Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Issuer) CIK: 0001994702 (see all company filings)

EIN.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)